ZEPOSIA (ozanimod) Patient Assistance Program
Don’t let the cost of brand specialty MS or UC therapy disrupt your treatment. We help eligible patients access Zeposia (ozanimod) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Zeposia (ozanimod) is FDA-approved for relapsing forms of multiple sclerosis (clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive disease in adults) and for moderately to severely active ulcerative colitis in adults.
- Without assistance, the list price is approximately $9,061 for the 28-dose starter titration kit and approximately $9,708 per 30-day maintenance-dose supply. Annual costs commonly reach $115,000–$120,000.
- Through AffordMyPrescriptions, qualifying patients can access Zeposia for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no commercially available generic version of Zeposia in the U.S. as of 2026; an FDA tentative approval has been issued for a generic, but commercial entry is not expected until patent and exclusivity protections lapse later in the next decade.
What is Zeposia Prescription Assistance Program?
The Zeposia Prescription Assistance Program is a manufacturer-sponsored initiative that provides Zeposia at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for uninsured and underinsured individuals, as well as Medicare Part D beneficiaries who cannot afford specialty MS or UC therapy.
Navigating the program on your own means dealing with eligibility verification, prescriber coordination, baseline workup documentation (ECG, blood counts, varicella immunity, liver function, eye exam), and renewal deadlines — all while managing a chronic condition that requires consistent daily therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Zeposia costs approximately $9,061 for the starter titration kit and $9,708 per month at the maintenance dose. Discount coupons offer some relief, but they don't come close to what a Patient Assistance Program provides — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$9,800.00 | Save ~$9,730/mo |
| CVS Pharmacy | ~$9,900.00 | Save ~$9,830/mo |
| Walmart | ~$9,500.00 | Save ~$9,430/mo |
| Costco | ~$9,200.00 | Save ~$9,130/mo |
| Kroger | ~$9,400.00 | Save ~$9,330/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Zeposia Prescription Program?
The Patient Assistance Program is free to apply for and provides Zeposia at little or no medication cost if approved. But the process involves detailed applications, prescriber coordination, baseline workup documentation, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, refill management, and annual re-enrollment — so you focus on your treatment, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Zeposia:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $9,061–$9,900 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Zeposia assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Zeposia Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Zeposia:
Zeposia (ozanimod) is a once-daily oral prescription medicine used to treat relapsing forms of multiple sclerosis (MS) in adults and moderately to severely active ulcerative colitis (UC) in adults. It belongs to a class of medicines called sphingosine 1-phosphate (S1P) receptor modulators and is taken on a structured 7-day starter titration before reaching the daily maintenance dose.
How It Works:
Zeposia treats relapsing multiple sclerosis and ulcerative colitis by targeting specific receptors that control the movement of immune cells. It keeps these cells trapped inside lymph nodes, which prevents them from traveling to the brain, spinal cord, or colon where they cause inflammation. By reducing the number of circulating lymphocytes in the bloodstream, the drug effectively dampens the immune response that leads to nerve damage and intestinal ulceration.
Form and Use:
This medication is an oral capsule taken once daily, with or without food, at approximately the same time each day. Treatment begins with a specific seven-day titration schedule, starting at 0.23 mg and gradually increasing to a full maintenance dose of 0.92 mg by the eighth day. A starter pack is typically provided to help patients follow this initial dosing transition easily.
Generic Availability:
As of 2026, there is no commercially available generic version of Zeposia in the U.S. due to existing patent protections. Although the FDA has issued a tentative approval for a generic, reports suggest it may not be launched until later in the next decade. While other therapies for MS and ulcerative colitis exist—some with generic or biosimilar options—any switch in treatment is a decision that must be made by your prescriber.
Warnings:
Zeposia carries risks of serious infections, liver injury, increased blood pressure, and a transient slowing of the heart rate. Before starting therapy, patients usually require a comprehensive medical screening, including an ECG, blood counts, liver tests, and an eye exam. Additionally, the medication should not be used during pregnancy, and patients should be monitored for potential skin malignancies or lung function declines.
FAQ (Frequently Asked Questions)
How Much Does Zeposia Cost Without Insurance?
The list price is approximately $9,061 for the 28-dose starter titration kit and approximately $9,708 per 30-day maintenance-dose supply. Even with publicly listed coupons at major pharmacies, the underlying price remains in the high four figures per month. Through AffordMyPrescriptions, qualifying patients receive Zeposia at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Is The Starter Titration Important?
S1P receptor modulators can briefly slow the heart rate when first started, so the dose is increased gradually over the first week to make that transition safer. Your prescriber may also order an electrocardiogram (ECG) and check blood counts, varicella immunity, liver function, and other tests before starting therapy, depending on your medical history.
How Does Zeposia Compare To Other MS Or UC Therapies?
For relapsing MS, Zeposia is one of several oral therapies (other examples include fingolimod, dimethyl fumarate, and teriflunomide), and there are also injectable and infusion options. For ulcerative colitis, Zeposia is one of several newer oral and biologic options. Whether Zeposia is
a better fit than another therapy depends on your prior treatments, comorbidities, and other factors. We mention this directly because if a different therapy on a more accessible assistance pathway would work for your situation, that may be a better path than paying for our advocacy on Zeposia.
Can I Get Zeposia Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Zeposia Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program ($0 per 30-day supply for eligible patients) is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including the manufacturer’s reported bridge program that may provide Zeposia at no medication cost for an extended period for eligible patients, the manufacturer’s copay savings program if you have commercial insurance, the National Multiple Sclerosis Society or the Crohn’s & Colitis Foundation, independent foundations such as the PAN Foundation or HealthWell Foundation, or asking your prescriber whether a different MS or UC therapy on a more accessible assistance pathway would work for you. If we cannot find a path to medication access, you will not be charged our service fee.
How Long Does It Take To Get Approved?
Most enrolled patients receive their first Zeposia shipment within two to four weeks of completing the documentation. Timing depends on how quickly your prescriber returns the required forms and the program processes your application.
Take Control of Your Medication Costs
If you are struggling with the high cost of Zeposia, our team may be able to help you access assistance programs designed to make brand specialty MS or UC therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.